![Sorafenib as second‐line treatment option after failure of lenvatinib in patients with unresectable hepatocellular carcinoma - Tomonari - 2020 - JGH Open - Wiley Online Library Sorafenib as second‐line treatment option after failure of lenvatinib in patients with unresectable hepatocellular carcinoma - Tomonari - 2020 - JGH Open - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/ab35959e-4ed0-48f8-a7a9-673f31bfccbf/jgh312408-fig-0002-m.jpg)
Sorafenib as second‐line treatment option after failure of lenvatinib in patients with unresectable hepatocellular carcinoma - Tomonari - 2020 - JGH Open - Wiley Online Library
![The Role of Glypicans in Cancer Progression and Therapy - Nan Li, Madeline R. Spetz, Mitchell Ho, 2020 The Role of Glypicans in Cancer Progression and Therapy - Nan Li, Madeline R. Spetz, Mitchell Ho, 2020](https://journals.sagepub.com/cms/10.1369/0022155420933709/asset/images/large/10.1369_0022155420933709-fig1.jpeg)
The Role of Glypicans in Cancer Progression and Therapy - Nan Li, Madeline R. Spetz, Mitchell Ho, 2020
![Small Molecule Kinase Inhibitor Drugs (1995–2021): Medical Indication, Pharmacology, and Synthesis | Journal of Medicinal Chemistry Small Molecule Kinase Inhibitor Drugs (1995–2021): Medical Indication, Pharmacology, and Synthesis | Journal of Medicinal Chemistry](https://pubs.acs.org/cms/10.1021/acs.jmedchem.1c00963/asset/images/medium/jm1c00963_0004.gif)
Small Molecule Kinase Inhibitor Drugs (1995–2021): Medical Indication, Pharmacology, and Synthesis | Journal of Medicinal Chemistry
![IJMS | Free Full-Text | Specificity Proteins (SP) and Krüppel-like Factors (KLF) in Liver Physiology and Pathology IJMS | Free Full-Text | Specificity Proteins (SP) and Krüppel-like Factors (KLF) in Liver Physiology and Pathology](https://pub.mdpi-res.com/ijms/ijms-24-04682/article_deploy/html/images/ijms-24-04682-g001.png?1677577905)
IJMS | Free Full-Text | Specificity Proteins (SP) and Krüppel-like Factors (KLF) in Liver Physiology and Pathology
![Discovery of synthetic lethal interactions from large-scale pan-cancer perturbation screens | Nature Communications Discovery of synthetic lethal interactions from large-scale pan-cancer perturbation screens | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-022-35378-z/MediaObjects/41467_2022_35378_Fig1_HTML.png)